Cytosorbents (CTSO) Enterprise Value (QoQ) (2010 - 2026)
Cytosorbents (CTSO) Enterprise Value (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn |
| 10 | Cytosorbents | 21.98 Mn | 17.56 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.31% |
| Mar 31, 2026 | 23.19% |
| Dec 31, 2025 | 17.08% |
| Sep 30, 2025 | 26.15% |
| Jun 30, 2025 | 22.17% |
| Mar 31, 2025 | 11.20% |
| Dec 31, 2024 | -127.14% |
| Sep 30, 2024 | 23.16% |
| Jun 30, 2024 | 1.74% |
| Mar 31, 2024 | 39.08% |
| Dec 31, 2023 | -69.05% |
| Sep 30, 2023 | 36.44% |
| Jun 30, 2023 | 30.96% |
| Mar 31, 2023 | 13.98% |
| Dec 31, 2022 | 1.81% |
| Sep 30, 2022 | 25.23% |
| Jun 30, 2022 | 29.89% |
| Mar 31, 2022 | 17.48% |
| Dec 31, 2021 | 14.59% |
| Sep 30, 2021 | 6.96% |